BLADDER TRANSITIONAL CELL CARCINOMA

This adverse event was reported 1433 times

These drugs are most commonly taken by patients reporting BLADDER TRANSITIONAL CELL CARCINOMA:

# Drug Count
0 PIOGLITAZONE 540
1 METFORMIN 174
2 METFORMIN ER 500 MG 174
3 METFORMIN ER 750 MG 174
4 METHOTREXATE SODIUM 131
5 ADALIMUMAB 117
6 METHOTREXATE 115
7 INFLIXIMAB 87
8 GLIPIZIDE 77
9 SITAGLIPTIN 76
See all common drugs associated with BLADDER TRANSITIONAL CELL CARCINOMA

BLADDER TRANSITIONAL CELL CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FOSFOMYCIN TROMETHAMINE 20 0.0327
1 CEFPODOXIME PROXETIL 21 0.0212
2 PIOGLITAZONE AND METFORMIN HYDROCHLORIDE 20 0.0158
3 PIOGLITAZONE 540 0.0125
4 HYDROCORTISONE BUTYRATE 20 0.0101
5 CLINDAMYCIN HYDROCHLORIDE 21 0.0060
6 AMPICILLIN 25 0.0030
7 AMPHOTERICIN B 20 0.0016
8 SIROLIMUS 19 0.0014
9 GLIPIZIDE 77 0.0013
See all drugs enriched for association with BLADDER TRANSITIONAL CELL CARCINOMA